Senate Resolution No. recognizes October 2025 as Uterine Fibroids Awareness Month to highlight the prevalence and impact of uterine fibroids, which are non-cancerous growths that can cause significant health issues for women, including pelvic pain, reproductive dysfunction, and infertility. The resolution emphasizes that approximately 26 million women in the U.S. are affected by this condition, with a higher incidence among women of color, particularly Black women, who are diagnosed at a much higher rate than their Caucasian counterparts. The resolution also points out the economic burden of uterine fibroids, estimated at $42.2 billion annually, due to medical costs and lost productivity.

The resolution calls for increased public awareness and education regarding uterine fibroids to improve understanding, prevention, screening, diagnosis, and treatment options. It urges further research and data collection to address the disparities in care and outcomes for women of color affected by this condition. By designating October 2025 as Uterine Fibroids Awareness Month, the Senate aims to promote dialogue and action surrounding this common yet often overlooked health issue.